Anne C. Andorn

988 total citations
33 papers, 822 citations indexed

About

Anne C. Andorn is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Anne C. Andorn has authored 33 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Anne C. Andorn's work include Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Anne C. Andorn is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Anne C. Andorn collaborates with scholars based in United States, Italy and United Kingdom. Anne C. Andorn's co-authors include Rajesh N. Kalaria, Miguel A. Pappolla, James R. Unnerstall, Sami I. Harik, Massimo Tabaton, Peter J. Whitehouse, Nikolaos K. Robakis, Yau‐Jan Chyan, Rawhi Omar and Michael E. Maguire and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Free Radical Biology and Medicine.

In The Last Decade

Anne C. Andorn

33 papers receiving 796 citations

Peers

Anne C. Andorn
Mehrak Javadi‐Paydar Iran
S.K. Kulkarni India
Sylwia Fidecka Poland
Bonnie M. Davis United States
P.L. Sharma India
Faruk Erden Türkiye
M. Pomponi Italy
Carina Rodrigues Boeck Brazil
Ildikó Rácz Germany
Hamed Shafaroodi Iran
Mehrak Javadi‐Paydar Iran
Anne C. Andorn
Citations per year, relative to Anne C. Andorn Anne C. Andorn (= 1×) peers Mehrak Javadi‐Paydar

Countries citing papers authored by Anne C. Andorn

Since Specialization
Citations

This map shows the geographic impact of Anne C. Andorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne C. Andorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne C. Andorn more than expected).

Fields of papers citing papers by Anne C. Andorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne C. Andorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne C. Andorn. The network helps show where Anne C. Andorn may publish in the future.

Co-authorship network of co-authors of Anne C. Andorn

This figure shows the co-authorship network connecting the top 25 collaborators of Anne C. Andorn. A scholar is included among the top collaborators of Anne C. Andorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne C. Andorn. Anne C. Andorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Csernansky, John G., Robert A. Leadbetter, Anne C. Andorn, et al.. (2021). PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients. The Journal of Clinical Psychiatry. 82(5). 8 indexed citations
2.
Andorn, Anne C., Barbara R. Haight, Sunita Shinde, et al.. (2020). Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. Journal of Clinical Psychopharmacology. 40(3). 231–239. 31 indexed citations
3.
Andorn, Anne C., Jay A. Graham, John G. Csernansky, et al.. (2019). Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. 39(5). 428–433. 19 indexed citations
4.
Bani, Massimo, Anne C. Andorn, & Christian Heidbreder. (2013). Pharmacologically, are smokers the same as non-smokers?. Current Opinion in Pharmacology. 14. 42–49. 3 indexed citations
5.
Mugnaini, Manolo, Laura Iavarone, Cristiana Griffante, et al.. (2012). Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach. Neuropsychopharmacology. 38(2). 302–312. 68 indexed citations
6.
7.
Ghibellini, Giulia, Joo‐Hyun Park, Claire Brittain, et al.. (2009). Bupropion Has No Effect on Intraocular Pressure or Other Ophthalmologic Parameters After Single or Repeat Doses in Healthy Volunteers. The Journal of Clinical Pharmacology. 49(4). 489–495. 2 indexed citations
8.
Andorn, Anne C. & Miguel A. Pappolla. (2001). Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer’s disease brain. Free Radical Biology and Medicine. 31(3). 315–320. 23 indexed citations
9.
Andorn, Anne C., Robert S. Britton, Bruce R. Bacon, & R Kalaria. (1998). Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer disease. Molecular and Chemical Neuropathology. 33(1). 15–26. 5 indexed citations
10.
Andorn, Anne C., Robert S. Britton, & Bruce R. Bacon. (1996). Ascorbate‐Stimulated Lipid Peroxidation in Human Brain Is Dependent on Iron but Not on Hydroxyl Radical. Journal of Neurochemistry. 67(2). 717–722. 28 indexed citations
11.
Piletz, John E., et al.. (1991). Binding of [3H]-p-aminoclonidine to α2adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochemical Pharmacology. 42(3). 569–584. 46 indexed citations
12.
Kalaria, Rajesh N. & Anne C. Andorn. (1991). Adrenergic receptors in aging and Alzheimer's disease: Decreased α2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex. Neurobiology of Aging. 12(2). 131–136. 45 indexed citations
13.
Andorn, Anne C.. (1991). The low affinity component of [3H]clonidine binding is absent in the prefrontal cortex of presumptive suicide victims. Brain Research. 568(1-2). 276–278. 5 indexed citations
14.
Pappolla, Miguel A., Rosmarıa Omar, Anne C. Andorn, et al.. (1989). Concurrent neuroborreliosis and alzheimer's disease: Analysis of the evidence. Human Pathology. 20(8). 753–757. 23 indexed citations
15.
16.
17.
Kalaria, Rajesh N., Anne C. Andorn, & Sami I. Harik. (1988). ALTERATIONS IN ADRENERGIC RECEPTORS IN PREFRONTAL CORTEX AND IN CEREBRAL MICROVESSELS IN ALZHEIMER??S DISEASE AND NORMAL AGING. Alzheimer Disease & Associated Disorders. 2(3). 233–233. 3 indexed citations
18.
Pappolla, Miguel A. & Anne C. Andorn. (1987). Serum protein leakage in aged human brain and inhibition of ligand binding at alpha2‐ adrenergic and cholinergic binding sites. Synapse. 1(1). 82–89. 21 indexed citations
19.
Andorn, Anne C., et al.. (1986). Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain.. Proceedings of the National Academy of Sciences. 83(12). 4572–4575. 6 indexed citations
20.
Andorn, Anne C.. (1986). Do antipsychotic drugs and serotonin down regulate [3H]-spiroperidol binding sites in human cortex?. Life Sciences. 38(14). 1251–1260. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehrak Javadi‐Paydar Breakdown of academic impact, for papers by S.K. Kulkarni Breakdown of academic impact, for papers by Sylwia Fidecka Breakdown of academic impact, for papers by Bonnie M. Davis Breakdown of academic impact, for papers by P.L. Sharma Breakdown of academic impact, for papers by Faruk Erden Breakdown of academic impact, for papers by M. Pomponi Breakdown of academic impact, for papers by Carina Rodrigues Boeck Breakdown of academic impact, for papers by Ildikó Rácz Breakdown of academic impact, for papers by Hamed Shafaroodi
Rankless by CCL
2026